A Comparative Clinical Evaluation Of Dhanyak Gokshura Ghritam Uttar Basti And Khadir Beej Choorna Orally In Vatashthila (Benign Prostate Hyperplasia)
试验速览
- 阶段
- Phase 3 4
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- symptomatic relief, decrease in IPSS scoring, decrease in residual urine volume
研究概览
简要总结
· Vatashthila A Type Of Mutraghata Chiefly Presents The Features Related To The Lower Urinary Tract Symptoms (LUTS) And Can Be Co-Related With Benign Prostate Hyperplasia (BPH) . The Aim Of This Study Is To Compare The Effectiveness Of Khadir Beej Choorna Orally With Dhanyak Gokshura Ghritam Uttar Basti In Vatashthila (Benign Prostate Hyperplasia)..Study Will Be Done In Two Groups Each Having 20 Patients . Group A Will Be Given Dhanyak Gokshura Ghritam Uttar Basti And In Group B Dhanyak Gokshura Ghritam Uttar Basti along with Khadir Beej Choorna Orally For 21 Days. Inclusion Criteria Is Classical Symptoms Of *Vatashthila ,*Diagnosed Cases Of BPH Along With Lower Urinary Tract Symptoms, Age Between 40-70 Years, Grade 1 And 2 Prostate Enlargements Whereas Exclusion Criteria Is Serology Positive (Hiv, Hcv, Hbsag) VDRL ,Se. PSA Value
4ng/Ml, Prostate Carcinoma, Renal Failure, Recurrent UTI ,Urethral Stricture ,Uncontrolled Cases Of Hypertension, Diabetes Mellitus, Known Case Of Bleeding Disorders, Age Less Than 40 And More Than 70 Years. Primary Outcome Will Be Symptomatic Relief Along With Reduction In IPSS Score And Reduction In Residual Volume Whereas Secondary Outcome Will Be Reduction In Prostate Size which will be observed by USG findings
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 40.00 Year(s) 至 70.00 Year(s)(—)
- 性别
- Male
入选标准
- •Classical symptoms of Vatashthila, Diagnosed cases of BPH along with lower urinary tract symptoms, Age between 40-70 years, Grade 1 and 2 prostate enlargements.
排除标准
- •Diagnosed cases of, Serology positive (hiv, hcv, hbsag) VDRL, Se.PSA value more than 4ng/ml, Prostate carcinoma, Renal failure, Recurrent UTI, Urethral stricture, Uncontrolled cases of hypertension, diabetes mellitus,Known case of bleeding disorders, Age less than 40 and more than 70 years.
结局指标
主要结局
symptomatic relief, decrease in IPSS scoring, decrease in residual urine volume
时间窗: subjective parameters will be checked after end of every cycle and objective parameters at the end of treatment of 21 days
次要结局
- Reduction Of Size Of Prostate(Baseline to 21st day)
研究者
Satinderpal Singh
Quadra Institute Of Ayurveda and hospital roorkee haridwar
